North America’s medical devices industry saw a drop of 30.23% in deal activity during January 2021, when compared with the last 12-month average, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 60 medical devices industry deals worth $22.38bn were announced for the region in January 2021, against the 12-month average of 86 deals.
Of all the deal types, venture financing saw most activity in January 2021 with 27 transactions, representing a 45% share for the region.
In second place was M&A with 26 deals, followed by private equity deals with seven transactions, respectively capturing a 43.3% and 11.7% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $21.21bn, while venture financing and private equity deals totalled $936.83m and $233.21m, respectively.
North America medical devices industry deals in January 2021: Top deals
The top five medical devices deals accounted for 89.4% of the overall value during January 2021.
The combined value of the top five medical devices deals stood at $20.01bn, against the overall value of $22.38bn recorded for the month.
The top five medical devices industry deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition deal with Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $635m acquisition of Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.